The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 339:687-688 September 3, 1998 Number 10
NextNext

Pancreatitis and Mutations of the Cystic Fibrosis Gene

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Sharer, N.
-Related Article
 by Cohn, J. A.
-PubMed Citation
In patients with cystic fibrosis, the inability to maintain the luminal hydration of ducts that contain or secrete large molecules may affect multiple organs. The protein product of the gene that causes the disease — the cystic fibrosis transmembrane conductance regulator (CF TR) gene — functions as a cyclic AMP–regulated chloride channel.1 The exocrine pancreas and, in males, the wolffian ducts are most susceptible to the disease and are affected earliest. In both cases, high concentrations of macromolecules can block the narrow, tortuous, and lengthy ducts. Nevertheless, the severity of the disease varies considerably. This heterogeneity must be . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.